Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-25-272572

Chief Development Officer sold 20,000 shares at an average $75.36 ($1,507,122)

  • Chief Development Officer acquired 20,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Guyer William · Chief Development Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-05 Exercise or conversion : show line 1 in the form 10b5-1 +20,000 $21.65 $433,000 25,287 D
2025-11-05 Sale : show line 2 in the form 10b5-1 −6,536 $74.75 $488,559 18,751 D
2025-11-05 Sale : show line 3 in the form 10b5-1 −13,164 $75.64 $995,679 5,587 D
2025-11-05 Sale : show line 4 in the form 10b5-1 −300 $76.28 $22,884 5,287 D
Open-market sales · 20,000 sh · avg $75.36 · $1,507,122

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-11-05 Exercise or conversion : show line 5 in the form 10b5-1 Stock option (right to buy) −20,000 290,000 D
Loading xslF345X05/ownership.xml…